BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, February 24, 2026
Home » Authors » Tamra Sami

Articles by Tamra Sami

Australia maps out new CDx regulatory framework that mirrors EU regs

Nov. 7, 2018
By Tamra Sami
PERTH, Australia – Australia’s Therapeutic Goods Administration (TGA) is seeking industry comments on a proposal to introduce a new framework for companion diagnostics.
Read More

Australia aims to become regenerative medicine hub for the Asia Pacific region

Nov. 6, 2018
By Tamra Sami

Australia aims to become regenerative medicine hub for the Asia Pacific region

Nov. 6, 2018
By Tamra Sami
BRISBANE, Australia – Australia is considered one of the first movers in the regenerative medicine (RM) space, with more than 70 institutes and companies working in the sector across the country. But to capitalize on its technical capabilities, it will need to be strategic if it is to reach its potential to be a major player in Asia Pacific.
Read More

Australia maps out new CDx regulatory framework that mirrors EU regs

Nov. 1, 2018
By Tamra Sami
PERTH, Australia – Australia's Therapeutic Goods Administration (TGA) is seeking industry comments on a proposal to introduce a new framework for companion diagnostics.
Read More

Australia maps out new companion diagnostic regulatory framework that mirrors EU regs

Oct. 31, 2018
By Tamra Sami

Australia sets in motion mandatory requirements for patient implant cards

Oct. 25, 2018
By Tamra Sami

Australia launches first oncology registry trials

Oct. 24, 2018
By Tamra Sami
PERTH, Australia – Australia is kicking off its first-ever registry-based randomized controlled trials in oncology to help clinicians select the right treatments for the right patients.
Read More

Cochlear unveils plans to develop totally implantable device

Oct. 22, 2018
By Tamra Sami

Australia launches first oncology registry trials

Oct. 22, 2018
By Tamra Sami
PERTH, Australia – Australia is kicking off its first-ever registry-based randomized controlled trials in oncology to help clinicians select the right treatments for the right patients.
Read More

ANDHealth makes strides developing a robust digital health ecosystem in Australia

Oct. 18, 2018
By Tamra Sami
Previous 1 2 … 193 194 195 196 197 198 199 200 201 … 225 226 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

    BioWorld Science
    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
  • Illustration of head with maze that is missing parts

    Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

    BioWorld Science
    Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
  • Pill in immersive interface

    New mechanism of action identified for QC-6352

    BioWorld Science
    QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
  • Illustration of brain and antibodies

    VST Bio’s VB-001 is neuroprotector after stroke

    BioWorld Science
    At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing